ImmunityBio, Inc. (IBRX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

ImmunityBio, Inc. (IBRX) closed at USD 9.91 on 2026-10-14, a change of +284.1 % over the past year, with a market capitalization of USD 10.6B.

ImmunityBio, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ImmunityBio, Inc. key figures

Previous close

USD 9.91 (2026-10-14)

1-year change

+284.1 %

Market cap

USD 10.6B

Enterprise value

USD 11.47B

P/E ratio (trailing)

-10.42

P/E ratio (forward)

-71.43

EPS (trailing)

-0.96

EPS (forward)

-0.14

PEG ratio

n/a

Price to book

-10.06

Revenue growth

93.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

11.29

Employees

684

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ImmunityBio, Inc.

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ImmunityBio, Inc. and compare it with other stocks.